View the RELISPA FORTE TABLETS registration information details.
Back to drug list
ItemsDrug Registration information
ID2215
No2215
Brand NameRELISPA FORTE TABLETS
IngredientsDROTAVERINE HCL 80 MG
Dosage FormTABLET
Primary PackagingALU-ALU BLISTER
Storage
Shelf Life05 YEARS
Pack SizeBOX OF 20'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR SYMTOMATIC RELIEF OF SPASM IN INTESTINAL COLIC, BILIARY COLIC, URETERIC COLIC AND DYSMENORRHEA, IT IS ADVOCATED TO PREVENT PREMATURE LABOR AT TERM ANS ALSO TO AUGMENT LABOR WHILST LOWERING THE INCIDENC OF CERVICAL RUPTURE.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionYELLOW WITH GREENISH OR ORANGE TINT, OBLONG SHAPED TABLETS, ENGRAVED SEARLE ON ONE SIDE AND BREAKLINE ON THE OTHER SIDE
Note
License OwnerPOUNSAB PHARMA CO.,LTD
ManufacturerTHE SEARLE COMPANY LIMITED
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No05 I 5531/23
FDD Registration Date15/05/2023
Expiry Date14/05/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA